ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/10/22
Adma Biologics (ADMA) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 08/03/22
ADMA Biologics to Report Second Quarter 2022 Financial Results on August 10, 2022GlobeNewsWire • 08/03/22
ADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/11/22
ADMA Biologics Announces First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 05/11/22
ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022GlobeNewsWire • 05/04/22
ADMA Announces Live Poster Presentation and Symposium on Real-World Experience with ASCENIV™ at CIS 2022GlobeNewsWire • 04/01/22
ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM® from 24 to 36 MonthsGlobeNewsWire • 03/25/22
ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update, Including $175M Debt Refinance with Hayfin Capital ManagementGlobeNewsWire • 03/24/22
ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022GlobeNewsWire • 03/21/22
ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GAGlobeNewsWire • 03/07/22